T1	PROC 46 74	Estudio de extensión abierto
T2	Date 95 108	a largo plazo
T3	CHEM 112 134	treprostinil palmitilo
T4	LIVB 163 172	pacientes
#1	AnnotatorNotes T4	C0030705; Patients; Patient or Disabled Group
T5	DISO 177 207	hipertensión arterial pulmonar
#2	AnnotatorNotes T5	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T6	PROC 230 258	Estudio de extensión abierto
T7	PROC 264 310	evaluar la seguridad, tolerabilidad y eficacia
T8	Date 319 332	a largo plazo
T9	CHEM 336 358	treprostinil palmitilo
T10	LIVB 387 396	pacientes
#3	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 401 431	hipertensión arterial pulmonar
#4	AnnotatorNotes T11	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T12	LIVB 455 468	Participantes
T14	ANAT 503 527	arterias de los pulmones
T15	LIVB 554 567	Participantes
T16	DISO 572 602	hipertensión arterial pulmonar
#5	AnnotatorNotes T16	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T17	LIVB 632 645	Participantes
T18	PROC 665 671	visita
T19	PROC 682 693	tratamiento
#6	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	CHEM 777 781	TPPI
T21	DISO 790 793	HAP
#7	AnnotatorNotes T21	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T22	LIVB 799 812	participantes
T23	Neg_cue 841 843	no
T24	Negated 851 861	disponible
T25	Date 903 915	preinclusión
T26	Duration 958 964	un año
T27	PROC 971 977	visita
T28	PROC 988 999	tratamiento
#8	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	Date 1015 1027	preinclusión
T30	PROC 1033 1058	Evaluaciones de selección
T31	Duration 1145 1159	más de 30 días
T32	PROC 1169 1175	visita
T33	Date 1269 1281	preinclusión
T34	CHEM 1286 1290	TPPI
T35	DISO 1299 1302	HAP
#9	AnnotatorNotes T35	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T36	PROC 1328 1352	consentimiento informado
#10	AnnotatorNotes T36	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T37	LIVB 1391 1404	Participantes
T38	DISO 1434 1451	hipersensibilidad
#11	AnnotatorNotes T38	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T39	DISO 1454 1485	reacción adversa al medicamento
T40	CHEM 1560 1564	TPPI
T41	DISO 1573 1576	HAP
#12	AnnotatorNotes T41	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T42	LIVB 1601 1613	investigador
#13	AnnotatorNotes T42	C0035173; Research Personnel; Professional or Occupational Group
T43	Spec_cue 1615 1621	podría
T44	PROC 1634 1658	continuar el tratamiento
T45	CHEM 1663 1667	TPPI
T46	Spec_cue 1668 1673	puede
T49	LIVB 1714 1726	participante
T50	PROC 1744 1769	administración parenteral
T51	Route 1759 1769	parenteral
T52	CHEM 1773 1798	análogos de prostaciclina
T53	CHEM 1813 1816	TRE
T54	CHEM 1818 1830	epoprostenol
#14	AnnotatorNotes T54	C0033567; epoprostenol; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T55	CHEM 1915 1919	TPPI
T56	CHEM 1945 1970	análogos de prostaciclina
T57	Route 1971 1980	inhalados
T58	CHEM 1995 1998	TRE
#15	AnnotatorNotes T58	C0014935; Estrogen Replacement Therapy; Therapeutic or Preventive Procedure
T59	CHEM 2000 2006	Tyvaso
T60	CHEM 2011 2019	iloprost
#16	AnnotatorNotes T60	C0079594; iloprost; Organic Chemical · Pharmacologic Substance
T61	CHEM 2023 2055	análogos orales de prostaciclina
T62	Route 2032 2038	orales
T63	CHEM 2070 2073	TRE
#17	AnnotatorNotes T63	C0014935; Estrogen Replacement Therapy; Therapeutic or Preventive Procedure
T64	CHEM 2075 2084	Orenitram
T65	CHEM 2090 2112	agonistas del receptor
T66	CHEM 2127 2136	selexipag
#18	AnnotatorNotes T66	C2000145; selexipag; Organic Chemical · Pharmacologic Substance
T67	Duration 2154 2162	24 horas
T68	PROC 2186 2212	administración del fármaco
T69	PHYS 2229 2237	Embarazo
#19	AnnotatorNotes T69	C0032961; Pregnancy; Organism Function
T70	PHYS 2240 2249	lactancia
#20	AnnotatorNotes T70	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T71	DISO 2264 2293	afección médica o psicológica
T72	LIVB 2381 2393	investigador
#21	AnnotatorNotes T72	C0035173; Research Personnel; Professional or Occupational Group
T73	DISO 2407 2417	enfermedad
#22	AnnotatorNotes T73	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T74	Spec_cue 2458 2463	pueda
T75	Speculated 2477 2495	riesgo irrazonable
T77	LIVB 2504 2516	participante
T78	Form 362 367	polvo
T79	Route 373 383	inhalación
T80	Form 138 143	polvo
T81	Route 149 159	inhalación
T13	DISO 473 495	tension sanguínea alta
T82	Date 761 773	preinclusión
T85	DISO 2309 2333	anomalías de laboratorio
T47	Speculated 1687 1705	riesgo irrazonable
